Literature DB >> 26389690

Disrupted TSH Receptor Expression in Female Mouse Lung Fibroblasts Alters Subcellular IGF-1 Receptor Distribution.

Stephen J Atkins1, Stephen I Lentz1, Roshini Fernando1, Terry J Smith1.   

Abstract

A relationship between the actions of TSH and IGF-1 was first recognized several decades ago. The close physical and functional associations between their respective receptors (TSHR and IGF-1R) has been described more recently in thyroid epithelium and human orbital fibroblasts as has the noncanonical behavior of IGF-1R. Here we report studies conducted in lung fibroblasts from female wild-type C57/B6 (TSHR(+/+)) mice and their littermates in which TSHR has been knocked out (TSHR(-/-)). Flow cytometric analysis revealed that cell surface IGF-1R levels are substantially lower in TSHR(-/-) fibroblasts compared with TSHR(+/+) fibroblasts. Confocal immunofluorescence microscopy revealed similar divergence with regard to both cytoplasmic and nuclear IGF-1R. Western blot analysis demonstrated both intact IGF-1R and receptor fragments in both cellular compartments. In contrast, IGF-1R mRNA levels were similar in fibroblasts from mice without and with intact TSHR expression. IGF-1 treatment of TSHR(+/+) fibroblasts resulted in reduced nuclear and cytoplasmic staining for IGF-1Rα, whereas it enhanced the nuclear signal in TSHR(-/-) cells. In contrast, IGF-1 enhanced cytoplasmic IGF-1Rβ in TSHR(-/-) fibroblasts while increasing the nuclear signal in TSHR(+/+) cells. These findings indicate the intimate relationship between TSHR and IGF-1R found earlier in human orbital fibroblasts also exists in mouse lung fibroblasts. Furthermore, the presence of TSHR in these fibroblasts influenced not only the levels of IGF-1R protein but also its subcellular distribution and response to IGF-1. They suggest that the mouse might serve as a suitable model for delineating the molecular mechanisms overarching these two receptors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26389690      PMCID: PMC4655214          DOI: 10.1210/en.2015-1464

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  30 in total

1.  Low TSH requirement and goiter in transgenic mice overexpressing IGF-I and IGF-Ir receptor in the thyroid gland.

Authors:  S Clément; S Refetoff; B Robaye; J E Dumont; S Schurmans
Journal:  Endocrinology       Date:  2001-12       Impact factor: 4.736

Review 2.  Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid associated ophthalmopathy.

Authors:  R Paschke; G Vassart; M Ludgate
Journal:  Clin Endocrinol (Oxf)       Date:  1995-06       Impact factor: 3.478

3.  Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice.

Authors:  R C Marians; L Ng; H C Blair; P Unger; P N Graves; T F Davies
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-13       Impact factor: 11.205

4.  Real-time PCR provides evidence for thyrotropin receptor mRNA expression in orbital as well as in extraorbital tissues.

Authors:  Patrizia Agretti; Luca Chiovato; Giuseppina De Marco; Claudio Marcocci; Barbara Mazzi; Stefano Sellari-Franceschini; Paolo Vitti; Aldo Pinchera; Massimo Tonacchera
Journal:  Eur J Endocrinol       Date:  2002-12       Impact factor: 6.664

5.  Regulation of thyrotropin receptor gene expression in 3T3-L1 adipose cells is distinct from its regulation in FRTL-5 thyroid cells.

Authors:  H Shimura; K Haraguchi; T Endo; T Onaya
Journal:  Endocrinology       Date:  1997-04       Impact factor: 4.736

6.  Molecular cloning of the thyrotropin receptor.

Authors:  M Parmentier; F Libert; C Maenhaut; A Lefort; C Gérard; J Perret; J Van Sande; J E Dumont; G Vassart
Journal:  Science       Date:  1989-12-22       Impact factor: 47.728

7.  Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue.

Authors:  A Feliciello; A Porcellini; I Ciullo; G Bonavolontà; E V Avvedimento; G Fenzi
Journal:  Lancet       Date:  1993-08-07       Impact factor: 79.321

Review 8.  Structural biology of insulin and IGF1 receptors: implications for drug design.

Authors:  Pierre De Meyts; Jonathan Whittaker
Journal:  Nat Rev Drug Discov       Date:  2002-10       Impact factor: 84.694

9.  Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway.

Authors:  Jane Pritchard; Rui Han; Noah Horst; William W Cruikshank; Terry J Smith
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

10.  Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG.

Authors:  D Tramontano; G W Cushing; A C Moses; S H Ingbar
Journal:  Endocrinology       Date:  1986-08       Impact factor: 4.736

View more
  6 in total

1.  Thyrotropin and Insulin-Like Growth Factor 1 Receptor Crosstalk Upregulates Sodium-Iodide Symporter Expression in Primary Cultures of Human Thyrocytes.

Authors:  Sarah J Morgan; Susanne Neumann; Bernice Marcus-Samuels; Marvin C Gershengorn
Journal:  Thyroid       Date:  2016-10-18       Impact factor: 6.568

2.  Teprotumumab Divergently Alters Fibrocyte Gene Expression: Implications for Thyroid-associated Ophthalmopathy.

Authors:  Roshini Fernando; Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2022-09-28       Impact factor: 6.134

3.  TSH Receptor Signaling Abrogation by a Novel Small Molecule.

Authors:  Rauf Latif; Ronald B Realubit; Charles Karan; Mihaly Mezei; Terry F Davies
Journal:  Front Endocrinol (Lausanne)       Date:  2016-09-27       Impact factor: 5.555

Review 4.  Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Front Endocrinol (Lausanne)       Date:  2017-01-03       Impact factor: 5.555

Review 5.  Teprotumumab as a Novel Therapy for Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-17       Impact factor: 5.555

6.  It takes two to Tango: IGF-I and TSH Receptors in Thyroid Eye Disease.

Authors:  Leonard Girnita; Terry J Smith; Joseph A M J L Janssen
Journal:  J Clin Endocrinol Metab       Date:  2022-02-15       Impact factor: 6.134

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.